TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway

被引:0
|
作者
Yanqing Ye
Maosheng Liu
Fengfei Wu
Shiyu Ou
Weidong Wang
Jieying Fei
Fang Xie
Lan Bai
机构
[1] Southern Medical University,Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital
[2] The First Affiliated Hospital of Gannan Medical University,Department of Gastroenterology
[3] The Fourth Affiliated Hospital of Guangxi Medical University,Department of Gastroenterology
关键词
Hepatocellular carcinoma; Cell proliferation; TRMT6; PI3K/AKT; mTOR;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Ye, Yanqing
    Liu, Maosheng
    Wu, Fengfei
    Ou, Shiyu
    Wang, Weidong
    Fei, Jieying
    Xie, Fang
    Bai, Lan
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [2] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
    Yu, Xinxin
    Zheng, Yan
    Zhu, Xuchao
    Gao, Xiaomei
    Wang, Chaoqun
    Sheng, Yuanyuan
    Cheng, Wei
    Qin, Lunxiu
    Ren, Ning
    Jia, Huliang
    Dong, Qiongzhu
    [J]. ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
  • [3] NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
    Gong, Chengwu
    Ai, Jiyuan
    Fan, Yun
    Gao, Jun
    Liu, Weiwei
    Feng, Qian
    Liao, Wenjun
    Wu, Linquan
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 8537 - 8552
  • [4] COPS8 promotes hepatocellular carcinoma progression through the PI3K/AKT/mTOR pathway
    Yan, Xiaodong
    Li, Zhongmin
    Tian, Qing
    Zhang, Yamin
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2947 - 2949
  • [5] ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway
    Chen, Han
    Wang, Hengxiao
    Yu, Xiqiao
    Zhou, Shuping
    Zhang, Yueying
    Wang, Zhaopeng
    Huang, Shuhong
    Wang, Zhaoxia
    [J]. BMC CANCER, 2020, 20 (01)
  • [6] ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway
    Han Chen
    Hengxiao Wang
    Xiqiao Yu
    Shuping Zhou
    Yueying Zhang
    Zhaopeng Wang
    Shuhong Huang
    Zhaoxia Wang
    [J]. BMC Cancer, 20
  • [7] PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
    Ding, Yifeng
    Wang, Xiaoqing
    Shu, Fei
    Pan, Kehua
    Chen, Xiaohong
    Liu, Qingquan
    [J]. JOURNAL OF MOLECULAR HISTOLOGY, 2024,
  • [8] CURZERENE SUPPRESSES HEPATOCELLULAR CARCINOMA PROGRESSION THROUGH THE PI3K/AKT/MTOR PATHWAY
    Luo, Yihui
    Wang, Zhenchang
    Jiang, Jun'e
    Wu, Shanshan
    Zhai, Yang
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2024,
  • [9] Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway
    Shanshan S Wang
    Yuhan H Chen
    Ning Chen
    Lijun J Wang
    Dexi X Chen
    Honglei L Weng
    Steven Dooley
    Huiguo G Ding
    [J]. Cell Death & Disease, 2017, 8 : e2688 - e2688
  • [10] Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway
    Wang, Shanshan S.
    Chen, Yuhan H.
    Chen, Ning
    Wang, Lijun J.
    Chen, Dexi X.
    Weng, Honglei L.
    Dooley, Steven
    Ding, Huiguo G.
    [J]. CELL DEATH & DISEASE, 2017, 8 : e2688 - e2688